Brunello N, Barbaccia M L, Chuang D M, Costa E
Neuropharmacology. 1982 Nov;21(11):1145-9. doi: 10.1016/0028-3908(82)90172-1.
The injection of desmethylimipramine (DMI) twice daily for 3 weeks reduced the density of beta-adrenergic receptor recognition sites located in crude synaptic membranes prepared from the cortex and hippocampus and attenuated the stimulation of the membrane-bound adenylate cyclase by isoproterenol. Both actions were abolished if prior to treatment with desmethylimipramine the serotonergic axons were destroyed by an intraventricular injection of 5,7-dihydroxytryptamine. These results show that the down-regulation of beta-adrenergic receptors elicited by repeated injections of desmethylimipramine occurs only if the serotonergic axons are intact.
每日两次注射去甲丙咪嗪(DMI),持续3周,可降低从皮质和海马制备的粗制突触膜中β-肾上腺素能受体识别位点的密度,并减弱异丙肾上腺素对膜结合腺苷酸环化酶的刺激作用。如果在去甲丙咪嗪治疗前,通过脑室内注射5,7-二羟色胺破坏血清素能轴突,则这两种作用均会消失。这些结果表明,只有当血清素能轴突完整时,反复注射去甲丙咪嗪引起的β-肾上腺素能受体下调才会发生。